These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12454313)

  • 1. Incorporating oral capecitabine into the treatment of breast cancer. Introduction.
    Seidman AD; Aapro M
    Oncologist; 2002; 7 Suppl 6():1-3. PubMed ID: 12454313
    [No Abstract]   [Full Text] [Related]  

  • 2. Capecitabine: fulfilling the promise of oral chemotherapy.
    Hwang JJ; Marshall JL
    Expert Opin Pharmacother; 2002 Jun; 3(6):733-43. PubMed ID: 12036413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral capecitabine (Xeloda) in cancer treatment.
    Doyle DP; Engelking C
    Nurse Pract; 2007 Feb; 32(2):18-21. PubMed ID: 17264789
    [No Abstract]   [Full Text] [Related]  

  • 4. Capecitabine dosing is not yet optimized for breast cancer.
    Hudis C; Traina T; Norton L
    Ann Oncol; 2010 Nov; 21(11):2291; author reply 2291-2. PubMed ID: 20501505
    [No Abstract]   [Full Text] [Related]  

  • 5. Capecitabine: have we got the dose right?
    Midgley R; Kerr DJ
    Nat Clin Pract Oncol; 2009 Jan; 6(1):17-24. PubMed ID: 18936793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimising the dose of capecitabine in metastatic breast cancer: confused, clarified or confirmed?
    Zielinski C; Gralow J; Martin M
    Ann Oncol; 2010 Nov; 21(11):2145-2152. PubMed ID: 20332132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xeloda in colorectal cancer.
    Cassidy J
    Int J Clin Pract; 2001 Jun; 55(5):326-8. PubMed ID: 11452682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation.
    Milano G; Ferrero JM; François E
    Br J Cancer; 2004 Aug; 91(4):613-7. PubMed ID: 15280932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function.
    Schüll B; Scheithauer W; Kornek GV
    Onkologie; 2003 Dec; 26(6):578-80. PubMed ID: 14709934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How the new oral antineoplastics affect nursing practice: capecitabine serves to illustrate.
    Szetela AB; Gibson DE
    Am J Nurs; 2007 Dec; 107(12):40-8; quiz 48-9. PubMed ID: 18049060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer.
    Wist EA; Sommer HH; Ostenstad B; Risberg T; Bremnes Y; Mjaaland I
    Acta Oncol; 2004; 43(2):186-9. PubMed ID: 15163168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatic response of recalcitrant warts as a side effect of colorectal cancer treatment with oral capecitabine.
    Bel B; Lorton MH; Darut-Jouve A; Vabres P
    Eur J Dermatol; 2011; 21(5):789-90. PubMed ID: 21700544
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.
    Traina TA; Theodoulou M; Feigin K; Patil S; Tan KL; Edwards C; Dugan U; Norton L; Hudis C
    J Clin Oncol; 2008 Apr; 26(11):1797-802. PubMed ID: 18398145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological and clinical properties of Xeloda (Capecitabine), a new oral active derivative of fluoropyrimidine].
    Nishida M
    Nihon Yakurigaku Zasshi; 2003 Dec; 122(6):549-53. PubMed ID: 14639009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer?
    Seidman AD; O'Shaughnessy J; Misset JL
    Oncologist; 2002; 7 Suppl 6():20-8. PubMed ID: 12454316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving forward with capecitabine: a glimpse of the future.
    Biganzoli L; Martin M; Twelves C
    Oncologist; 2002; 7 Suppl 6():29-35. PubMed ID: 12454317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer.
    Cassata A; Procoplo G; Alù M; Ferrari L; Ferrario E; Beretta E; Longarini R; Busto G; De Candis D; Bajetta E
    Tumori; 2001; 87(6):364-71. PubMed ID: 11989587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary issues and the potential uses of capecitabine in metastatic breast cancer.
    Barrett-Lee P; Bidard FC; Pierga JY
    Cancer Treat Rev; 2009 Nov; 35(7):582-9. PubMed ID: 19632050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer.
    Ben-Josef E
    Am J Clin Oncol; 2007 Dec; 30(6):649-55. PubMed ID: 18091061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oral fluoropyrimidines in cancer chemotherapy.
    Lamont EB; Schilsky RL
    Clin Cancer Res; 1999 Sep; 5(9):2289-96. PubMed ID: 10499595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.